TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

FDA deals blow to Endo over Opana ER Pain Med
MARKETS

Biolinerx (blrx) stock soars on liver drug licensing agreement

  • By Annie Palmer
  • Sep 23, 2016 3:39 PM EDT
PRESS RELEASES

BioLineRx Announces Initiation Of Phase 1b Clinical Trial In Patients With Acute Respiratory Distress Syndrome (ARDS) Secondary To COVID-19 And Other Respiratory Viral Infections

  • By PR Newswire
  • Nov 18, 2020 7:00 AM EST
PRESS RELEASES

BioLineRx To Report Third Quarter 2020 Results On November 23, 2020

  • By PR Newswire
  • Nov 18, 2020 7:00 AM EST
PRESS RELEASES

BioLineRx Announces Positive Results From Interim Analysis Of GENESIS Phase 3 Trial Of Motixafortide (BL-8040) In Stem Cell Mobilization

  • By PR Newswire
  • Oct 30, 2020 7:00 AM EDT
PRESS RELEASES

BioLineRx Announces Initiation Of Phase 2 Clinical Trial In First-Line Metastatic Pancreatic Cancer

  • By PR Newswire
  • Oct 29, 2020 8:48 AM EDT
PRESS RELEASES

BioLineRx Achieves Enrollment Target In Phase 3 GENESIS Trial For Planned Interim Analysis

  • By PR Newswire
  • Aug 19, 2020 7:00 AM EDT
PRESS RELEASES

BioLineRx To Report Second Quarter 2020 Results On August 6, 2020

  • By PR Newswire
  • Jul 31, 2020 7:00 AM EDT
PRESS RELEASES

BioLineRx Announces $4.39 Million Registered Direct Offering

  • By PR Newswire
  • Jun 1, 2020 8:00 AM EDT
PRESS RELEASES

BioLineRx Announces $9.0 Million Registered Direct Offering

  • By PR Newswire
  • May 26, 2020 8:40 AM EDT
PRESS RELEASES

BioLineRx To Report First Quarter 2020 Results On May 20, 2020

  • By PR Newswire
  • May 15, 2020 7:00 AM EDT
PRESS RELEASES

BioLineRx Announces Notice Of Allowance From USPTO For Patent Covering Motixafortide (BL-8040) In Combination With Anti-PD-1 For The Treatment Of Any Type Of Cancer

  • By PR Newswire
  • Feb 27, 2020 7:43 AM EST
PRESS RELEASES

BioLineRx Completes Recruitment In Triple Combination Arm Of COMBAT/KEYNOTE-202 Study In Patients With Second-line Metastatic Pancreatic Cancer

  • By PR Newswire
  • Jan 22, 2020 7:00 AM EST
PRESS RELEASES

BioLineRx Receives Orphan Drug Designation For Motixafortide (BL-8040) For The Treatment Of Pancreatic Cancer In Europe

  • By PR Newswire
  • Jan 14, 2020 7:00 AM EST
PRESS RELEASES

BioLineRx To Present At The 2020 Biotech Showcase

  • By PR Newswire
  • Jan 8, 2020 7:00 AM EST
FDA deals blow to Endo over Opana ER Pain Med
MARKETS

Biolinerx (blrx) stock soars on liver drug licensing agreement

  • By Annie Palmer
  • Sep 23, 2016 3:39 PM EDT
5 Things You Must Know Before the Market Opens Friday
OPINION

7 stocks under $10 to trade for big profits

  • By Roberto Pedone
  • May 6, 2016 8:29 AM EDT
TrueCar Posts Another 1Q Loss, With In-Line Revenue
OPINION

These 7 stocks under $10 are making big moves to the upside

  • By Roberto Pedone
  • Apr 15, 2016 7:59 AM EDT
Pinnacle Entertainment (PNK) Stock Advances Despite Q2 Miss
MARKETS

BioLineRx (BLRX) Stock Down on Negative Heart Disease Treatment Results

  • By Tony Owusu
  • Jul 27, 2015 10:49 AM EDT
Dick's Sporting Goods (DKS) Stock Declines Pre-Market on Weak First Quarter SSS
MARKETS

Bioline RX (BLRX) Stock Gains on Positive Test Results, Coverage Initiation

  • By Tony Owusu
  • Jun 22, 2015 1:30 PM EDT
Cliffs Natural Resources (CLF) Stock Gains as Australia Issues Bullish Iron Ore Outlook
INVESTING

4 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Apr 7, 2015 2:16 PM EDT
Buy XOM 10% Cheaper With a Buy-Write Strategy
INVESTING

3 Stocks Under $10 Making Big Moves Higher

  • By Roberto Pedone
  • Mar 24, 2015 2:10 PM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Apr 18, 2013 2:24 PM EDT
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

BioLineRx Shares Fall On Schizophrenia Drug Failure

  • By Adam Feuerstein
  • Mar 20, 2013 11:23 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

4 Stocks Under $5 Making Big Moves

  • By Roberto Pedone
  • Feb 22, 2013 3:21 PM EST
Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

BioLineRx: Tuesday's Hot Hep C Drug Stock

  • By Adam Feuerstein
  • Jan 24, 2012 1:37 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.